Cardiothoracic imaging findings of Proteus syndrome

Table 3 Functional cardiac MRI information from a subset of 20 individuals with Proteus syndrome who underwent cardiac MRI.

Parameter (units)	Individuals with fat (n = 9)		Individuals without fat (n = 11)		P-value
Parameter (units)	Range	Mean ± SD	Range	Mean ± SD	P-value
LVEF (%)	53–69	60 ± 5	55–67	61 ± 4	0.56
LVEDV (ml)	64–245	132 ± 50	75–228	140 ± 42	0.72
LVESV (ml)	20–111	55 ± 26	25–103	55 ± 20	0.99
LVSV (ml)	44–134	77 ± 25	46–125	85 ± 23	0.50
CO (ml/min)	4–9	6 ± 1.5	4–8	6 ± 1	0.77
LVEDVI (ml/m²)	60–123	83 ± 19	63–121	84 ± 17	0.90
LVESVI (ml/m²)	21–49	33.5 ± 8	22–55	33 ± 10	0.93
LVSVI (ml/m²)	34–80	50 ± 13	38–66	51 ± 8	0.81
CI (ml/min/m²)	2–8.5	4 ± 2	3–5	4 ± 1	0.82
AS (mm)	4–13	7 ± 3	4–9	6 ± 1	0.30
PL (mm)	4–10	6 ± 1.5	3–7	6 ± 1	0.94

LVEF = left ventricular ejection fraction, LVEDV = left ventricular end-diastolic volume, LVESV = left ventricular end-systolic volume, LVSV = left ventricular stroke volume, CO = cardiac output, LVEDVI = left ventricular end-diastolic volume index, LVESVI = left ventricular end-systolic volume index, LVSVI = left ventricular stroke volume index, CI = cardiac index, AS = anteroseptal wall thickness, PL = posterolateral wall thickness.